George K. Ross, Director at ACURA PHARMACEUTICALS, INC (ACUR), bought 3,000 shares at $3.04 ($9K) on 2011-08-23, disclosed to the SEC on 2011-08-25.
Open-market purchase of $9k ACUR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.